Literature DB >> 8106419

Nerve growth factor induces transcription of transforming growth factor-beta 1 through a specific promoter element in PC12 cells.

S J Kim1, K Park, B B Rudkin, B R Dey, M B Sporn, A B Roberts.   

Abstract

Nerve growth factor (NGF) stimulates the differentiation of PC12 pheochromocytoma cells to those resembling sympathetic neurons. We have investigated whether NGF regulates transforming growth factor (TGF)-beta gene expression and protein secretion in PC12 cells. These cells constitutively express TGF-beta 1 mRNA, whereas TGF-beta 2 and -beta 3 mRNAs are expressed at very low levels. TGF-beta 1 gene expression was stimulated greater than 10-fold when PC12 cells were treated with NGF. Sequences between -119 and -98 in the TGF-beta 1 promoter, homologous to an Egr-1 binding site, were shown to be important for both basal and NGF-induced promoter activity. We also found that a factor(s) present in nuclear extracts from PC12 cells interacted with the sequences between -119 and -98 and that expression of this factor was induced by NGF treatment. Moreover, specific binding to TGF-beta 1 promoter fragments between -119 and -98 was seen using the bacterially expressed transcription factor Egr-1. These results indicate that activation of TGF-beta 1 expression is one of the cellular responses of PC12 cells to NGF and suggest that TGF-beta may play a role in the differentiation of sympathetic neurons.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8106419

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Blockade of NGF-induced neurite outgrowth by a dominant-negative inhibitor of the egr family of transcription regulatory factors.

Authors:  Y Levkovitz; K J O'Donovan; J M Baraban
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

2.  COUP-TF upregulates NGFI-A gene expression through an Sp1 binding site.

Authors:  C Pipaón; S Y Tsai; M J Tsai
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

3.  Structural and functional characterization of H2 haplotype MAPT promoter: unique neurospecific domains and a hypoxia-inducible element would enhance rationally targeted tauopathy research for Alzheimer's disease.

Authors:  Bryan Maloney; Debomoy K Lahiri
Journal:  Gene       Date:  2012-01-30       Impact factor: 3.688

4.  Tissue- and development-specific expression of multiple alternatively spliced transcripts of rat neuronal nitric oxide synthase.

Authors:  M A Lee; L Cai; N Hübner; Y A Lee; K Lindpaintner
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

5.  Novel mutants of NAB corepressors enhance activation by Egr transactivators.

Authors:  J Svaren; B R Sevetson; T Golda; J J Stanton; A H Swirnoff; J Milbrandt
Journal:  EMBO J       Date:  1998-10-15       Impact factor: 11.598

6.  Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis.

Authors:  Y D Yoo; H Ueda; K Park; K C Flanders; Y I Lee; G Jay; S J Kim
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

Review 7.  Alcohol-induced steatosis in liver cells.

Authors:  Terrence M Donohue
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

8.  Epidermal growth factor induces Egr-1 messenger RNA and protein in mouse osteoblastic cells.

Authors:  M A Fang; G M Noguchi; S McDougall
Journal:  Calcif Tissue Int       Date:  1995-12       Impact factor: 4.333

9.  Gene expression analysis of HCT116 colon tumor-derived cells treated with the polyamine analog PG-11047.

Authors:  Natalia A Ignatenko; Hagit F Yerushalmi; Ritu Pandey; Karen L Kachel; David E Stringer; Laurence J Marton; Eugene W Gerner
Journal:  Cancer Genomics Proteomics       Date:  2009 May-Jun       Impact factor: 4.069

10.  The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor beta1 gene through an Egr-1 binding site.

Authors:  Y D Yoo; C J Chiou; K S Choi; Y Yi; S Michelson; S Kim; G S Hayward; S J Kim
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.